Expert Opinion on Therapeutic Targets

Papers
(The H4-Index of Expert Opinion on Therapeutic Targets is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Potential role of indole-3-propionic acid in tuberculosis: current perspectives and future prospects91
Calcium channelopathies in neurodegenerative disorder: an untold story of RyR and SERCA68
The clinical and immunological features of alopecia areata following SARS-CoV-2 infection or COVID-19 vaccines49
Emergent RNA targets in cardiovascular disease: likely candidates for treatment development46
P2 receptors as emerging therapeutic targets in neglected parasitic diseases41
Mitochondrial permeability transition pore: a snapshot of a therapeutic target40
Interleukin-18 in cancer immunology and immunotherapy39
CDK7 as a New therapeutic target in pancreatic and lung cancer: current evidence and future perspectives39
Targeting transcription in neuroblastoma: focus on the core regulatory circuit36
Decoding the expression pattern of MUC3A in gastric adenocarcinoma: unveiling the key to successful immunotherapy33
Molecular basis for targeting TBK1 in CAR-T cell therapies for cancer32
Glycoproteins and longevity: an interview with Professor Gordan Lauc32
The protective role of SIRT1 in cardiovascular disease: from molecular mechanisms to potential therapeutic strategies28
The membrane receptor CD44: roles in neurodegenerative diseases28
Pleural mesothelioma: a snapshot of emerging drug targets and opportunities for non-surgical therapeutic advancement28
The sigma–1 receptor: a mechanistically–informed therapeutic target for antidepressants26
Blocking glycan production by targeting GALNT7 for prostate cancer therapy26
Kallikrein-related peptidases: mechanistic understanding for potential therapeutic targeting in cancer25
The role of human complement factor H in retinal immune response and the prospects for targeted therapy for age-related macular degeneration (AMD)25
Identification of target sites in the VHR (DUSP3) enzyme unlocking potential avenues for future sepsis treatment25
Current challenges in the discovery of treatments against Mayaro fever25
Advances in CGRP therapeutic targets for migraine: where do we stand 5 years later?24
The potential of multimolecular G-quadruplex structures for targeted treatment of Amyotrophic Lateral Sclerosis24
Lipid-laden foam cells in the pathology of atherosclerosis: shedding light on new therapeutic targets23
The challenges and potential of microRNA-based therapy for patients with liver failure syndromes and hepatocellular carcinoma23
MDA-9/Syntenin as a therapeutic cancer metastasis target: current molecular and preclinical understanding23
1.2107319831848